Novartis (NYSE:NVS) reported quarterly earnings of $1.99 per share which missed the analyst consensus estimate of $2.13 by 6.57 percent. This is a 12.72 percent decrease over earnings of $2.28 per share from the same period last year. The company reported quarterly sales of $13.113 billion which missed the analyst consensus estimate of $13.648 billion by 3.92 percent. This is a 0.91 percent decrease over sales of $13.233 billion the same period last year.